Taken all, ribosomal dysfunction-responsive PRDM1-IGF signaling contributed to cancer cell stemness and subsequent tumor cell survival from anticancer actions via preferential regulation of non-canonical Wnt-linked pathways (Fig. 9f). This evidence concerns the gene IGF1 and neoplasm.